ArticleFrontiers in medicine2026
Predictors of cough resolution following endoscopic minimally invasive treatment in patients with GERD and chronic cough: a retrospective study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To investigate factors influencing cough resolution following endoscopic minimally invasive treatment in patients with gastroesophageal reflux disease (GERD) complicated by chronic cough, and to establish a predictive model based on these findings. Methods: Clinical data from 200 patients with GERD and cough undergoing endoscopic minimally invasive treatment at our hospital between January and December 2024 were included. All patient data were extracted from the electronic medical record system. Patients were divided into a cough non-relief group ( Results: Compared to the cough-relief group, the non-relief group exhibited significantly higher age, smoking history, cough duration, ineffective esophageal motility, DeMeester score, esophageal dysfunction, pepsin, and exhaled nitric oxide (FeNO), along with lower secretory immunoglobulin A (SIgA) levels ( Conclusion: Independent risk factors influencing persistent cough after endoscopic minimally invasive treatment in GERD patients with chronic cough include ineffective esophageal motility, cough duration, DeMeester score, SIgA, pepsin, and FeNO. The nomogram model constructed based on these factors demonstrates good predictive efficacy for clinical treatment outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.